phase readout
saveNCT06788938: Tarlatamab in Advanced Delta-like 3 (DLL3)-Expressing Tumors Including Neuroendocrine Neoplasms
RECRUITINGupdated 20d ago
community read0 votes
Sponsor: Jonsson Comprehensive Cancer Center. Phase: PHASE2. Conditions: DLL3-expressing Tumors, Advanced Tumors
view source ↗
comments(0)
5-min edit window · permanent after that